Skip to content
10-Q

Quarterly Report

STANDARD BIOTOOLS INC. LAB

0001193125-25-264695

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 2, 2025 384.57M sh
Shares Diluted Q3 2025 · Sep 30, 2025 382.63M sh
Shares Diluted Q3 2025 · Sep 30, 2025 380.47M sh
Shares Diluted Q3 2025 · Sep 30, 2024 371.54M sh
Shares Diluted Q3 2025 · Sep 30, 2024 346.09M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $0
Stock Repurchased Q3 2025 · Sep 30, 2024 $40.49M
Capex Q3 2025 · Sep 30, 2025 $7.83M
Capex Q3 2025 · Sep 30, 2024 $4.97M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$73.15M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$129.4M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $129.42M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $166.73M
Stockholders Equity Q3 2025 · Sep 30, 2025 $399.66M
Stockholders Equity Q3 2025 · Jun 30, 2025 $424.54M
Stockholders Equity Q3 2025 · Mar 31, 2025 $454.6M
Stockholders Equity Q3 2025 · Dec 31, 2024 $471.72M
Stockholders Equity Q3 2025 · Sep 30, 2024 $489.33M
Stockholders Equity Q3 2025 · Jun 30, 2024 $510.26M
Stockholders Equity Q3 2025 · Mar 31, 2024 $577.32M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$148.05M
Current Liabilities Q3 2025 · Sep 30, 2025 $107.97M
Current Liabilities Q3 2025 · Dec 31, 2024 $65.9M
Total Liabilities Q3 2025 · Sep 30, 2025 $139.98M
Total Liabilities Q3 2025 · Dec 31, 2024 $140.62M
Current Assets Q3 2025 · Sep 30, 2025 $472.44M
Current Assets Q3 2025 · Dec 31, 2024 $375.88M
Total Assets Q3 2025 · Sep 30, 2025 $539.64M
Total Assets Q3 2025 · Dec 31, 2024 $612.35M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.09
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.25
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.07
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.44
Eps Basic Q3 2025 · Sep 30, 2025 −$0.09
Eps Basic Q3 2025 · Sep 30, 2025 −$0.25
Eps Basic Q3 2025 · Sep 30, 2024 −$0.07
Eps Basic Q3 2025 · Sep 30, 2024 −$0.44
Sga Expense Q3 2025 · Sep 30, 2025 $26.6M
Sga Expense Q3 2025 · Sep 30, 2025 $84.52M
Sga Expense restated Q3 2025 · Sep 30, 2024 $24.47M
Sga Expense restated Q3 2025 · Sep 30, 2024 $75.74M
Rd Expense Q3 2025 · Sep 30, 2025 $6.36M
Rd Expense Q3 2025 · Sep 30, 2025 $18.02M
Rd Expense restated Q3 2025 · Sep 30, 2024 $6.94M
Rd Expense restated Q3 2025 · Sep 30, 2024 $21.79M
Net Income Q3 2025 · Sep 30, 2025 −$34.69M
Net Income Q3 2025 · Sep 30, 2025 −$94.18M
Net Income Q3 2025 · Jun 30, 2025 −$33.46M
Net Income Q3 2025 · Mar 31, 2025 −$26.03M
Net Income Q3 2025 · Sep 30, 2024 −$26.94M
Net Income Q3 2025 · Sep 30, 2024 −$104.81M
Net Income Q3 2025 · Jun 30, 2024 −$45.72M
Net Income Q3 2025 · Mar 31, 2024 −$32.16M
Operating Income Q3 2025 · Sep 30, 2025 −$32.94M
Operating Income Q3 2025 · Sep 30, 2025 −$85.61M
Operating Income restated Q3 2025 · Sep 30, 2024 −$26.7M
Operating Income restated Q3 2025 · Sep 30, 2024 −$101.4M
Gross Profit Q3 2025 · Sep 30, 2025 $9.48M
Gross Profit Q3 2025 · Sep 30, 2025 $31.16M
Gross Profit restated Q3 2025 · Sep 30, 2024 $12.13M
Gross Profit restated Q3 2025 · Sep 30, 2024 $33.53M
Revenue Q3 2025 · Sep 30, 2025 $19.55M
Revenue Q3 2025 · Sep 30, 2025 $61.54M
Revenue restated Q3 2025 · Sep 30, 2024 $22.09M
Revenue restated Q3 2025 · Sep 30, 2024 $66.23M